Conquering Diseases

Study Of An Investigational Nasal Spray For Treatment Resistant Depression

Description

Seeking men and women with treatment resistant depression for a study of an investigational nasal spray.

Overview

Participants in this study will be randomly assigned to receive either the investigational drug or a placebo (looks like the drug, but contains no medicine) for 4 weeks. After that period, participants may be eligible to receive the investigational drug for up to an additional 3 months.

What we're hoping for

We are studying whether the investigational drug delivered as a nasal spray is safe and more effective for treatment resistant depression than a placebo (looks like the drug but contains no medicine).

Additional Information

ClinicalTrials.gov Identifier: NCT04599855

 Principal Investigator

Anthony  Rothschild, MD

UMass Memorial Health Care

 Study Contact

Chelsea  Kosma

+1 508-856-5312

chelsea.kosma@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989